Company Search:
Advanced Search
Sponsored Links
Oncogenex Pharmaceuticals, Incorporation Company Snapshot
Oncogenex Pharmaceuticals, Incorporation operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oncogenex Pharmaceuticals, Incorporation with three other companies in this sector in the United States: Akers Biosciences Incorporation (2016 sales of $2.96 million of which 100% was Diagnostic Screening), Celldex Therapeutics, Incorporation ($6.79 million of which 100% was Health Care Products), and Immunomedics, Inc. ($3.23 million of which 100% was Biopharma Products).

Sales Analysis. Sales fell dramatically in 2016: During the year ended December of 2016, sales at Oncogenex Pharmaceuticals, Incorporation were $5.06 million. This is a sharp decrease of 72.1% versus 2015, when the company's sales were $18.16 million. The sales level in 2016 was fairly close to the level five years ago: in 2011, Oncogenex Pharmaceuticals, Incorporation had sales of $5.50 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oncogenex Pharmaceuticals, Incorporation
  Stock Performance Chart for Oncogenex Pharmaceuticals, Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): .47
(Figures in U.S. Dollars)
1 Week 1.4%   13 Weeks 37.1%  
4 Weeks 25.9%   52 Weeks -48.2%  
Oncogenex Pharmaceuticals, Incorporation Key Data:
  Ticker: OGXI Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 5,062,000
(Year Ending Jan 2017).
Employees: 17
  Currency: U.S. Dollars Market Cap: 14,032,803
  Fiscal Yr Ends: December Shares Outstanding: 30,087,485
  Share Type: Common Closely Held Shares: 400,743
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.